https://www.daiichi-sankyo.de/ 2026-03-17T12:22:52+01:00 0.5 https://www.daiichi-sankyo.de/seite-nicht-gefunden/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/link-disclaimer/ 2022-11-17T09:26:14+01:00 0.5 https://www.daiichi-sankyo.de/download/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/services/suche/ 2026-03-16T11:30:58+01:00 0.5 https://www.daiichi-sankyo.de/impressum/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/services/so-finden-sie-uns/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/services/so-finden-sie-uns/mit-dem-flugzeug/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/services/so-finden-sie-uns/mit-der-bahn/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/services/so-finden-sie-uns/mit-dem-auto/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/disclaimer/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/services/download-center/ 2026-01-15T11:40:33+01:00 0.5 https://www.daiichi-sankyo.de/services/kontaktieren-sie-uns/ 2025-06-05T08:58:26+02:00 0.5 https://www.daiichi-sankyo.de/presse/ 2024-11-25T14:51:08+01:00 0.5 https://www.daiichi-sankyo.de/presse/pressekontakte/ 2025-06-02T12:20:22+02:00 0.5 https://www.daiichi-sankyo.de/presse/research-archive-2009/blood-pressure-goal-missed-by-two-thirds-of-patients/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/research-archive-2009/european-commission-approves-efientr-prasugrel/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/research-archive-2009/daiichi-sankyo-and-lilly-receive-us-fda-approval-for-effientr/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/research-archive-2009/edoxaban-next-generation-oral-anticoagulant-under-investigation-to-help-prevent-stroke-in-patients/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/research-archive-2009/ranbaxy-introducing-osteoporosis-drug-evistar-into-the-romanian-market/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/research-archive-2009/morphosys-and-daiichi-sankyo-forge-alliance-to-develop-novel-antibody-therapies/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/research-archive-2010/hokusai-vte-largest-single-phase-iii-trial-for-the-treatment-and-prevention-of-recurrent-vte-start/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/research-archive-2010/daiichi-sankyo-submits-first-new-drug-application-for-oral-factor-xa-inhibitor-edoxaban/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/research-archive-2010/arqule-and-daiichi-sankyo-expand-drug-discovery-collaboration-in-oncology/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/research-archive-2010/edoxaban-demonstrates-superior-efficacy-compared-with-enoxaparin-sodium-in-preventing-vte-after-total-hip-replacement/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/archiv-2009-1/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/archiv-2009-1/daiichi-sankyo-schliesst-rabattvertrag-mit-hallesche-krankenversicherung/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/archiv-2009-1/morphosys-und-daiichi-sankyo-schmieden-allianz-zur-entwicklung-neuartiger-antikoerpertherapien/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/archiv-2009-1/ausbau-der-kommunikation/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/archiv-2009-1/daiichi-sankyo-eroeffnet-hauptstadtbuero/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/archiv-2009-1/daimler-bkk-und-ikk-nord-treten-rahmenvertrag-fuer-blutdrucksenker-olmetecr-bei/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/archiv-2009-1/auszeichnung-fuer-absolventinnen-der-universitaet-muenchen/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/ueber-uns/verantwortung/ 2024-11-26T10:29:46+01:00 0.5 https://www.daiichi-sankyo.de/ueber-uns/verantwortung/csr-in-europa/ 2022-12-01T14:07:24+01:00 0.5 https://www.daiichi-sankyo.de/ueber-uns/wer-wir-sind/offenlegungspolitik/ 2022-12-01T14:07:24+01:00 0.5 https://www.daiichi-sankyo.de/forschung-innovation/ 2026-03-26T10:37:02+01:00 0.5 https://www.daiichi-sankyo.de/forschung-innovation/produkt-pipeline/ 2026-02-12T12:26:41+01:00 0.5 https://www.daiichi-sankyo.de/forschung-und-entwicklung/antithrombotische-mittel/ 2024-11-21T10:36:42+01:00 0.5 https://www.daiichi-sankyo.de/ueber-uns/ 2026-02-12T08:09:28+01:00 0.5 https://www.daiichi-sankyo.de/registrieren/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/logout/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/kardiovaskulaere-produkte/gebrauchsinformationen/ 2026-03-18T13:55:53+01:00 0.5 https://www.daiichi-sankyo.de/presse/archiv-2008/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/archiv-2009-1/daiichi-sankyo-deutschland-erhoeht-zahl-der-mitarbeiter/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/archiv-2009-1/daiichi-sankyo-staerkt-forschung-in-der-gentechnologie/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/archiv-2009-1/daiichi-sankyo-beste-pipeline-bei-herz-kreislauf-medikamenten/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/archiv-2009-1/daiichi-sankyo-uebernimmt-in-italien-kardiovaskulaeren-aussendienst-von-merck-serono/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/archiv-2009-1/daiichi-sankyo-und-taunus-bkk-schliessen-rabattvertraege/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/archiv-2009-1/zwei-drittel-der-patienten-erreichen-nicht-das-angestrebte-blutdruckziel/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/archiv-2009-1/daiichi-sankyo-deutschland-schliesst-rabattvertrag-mit-aok-rheinland/hambur/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/archiv-2008/daiichi-sankyos-prasugrel-erhaelt-positive-opinion-vom-eu-ausschuss-fuer-humanarzneimittel/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/archiv-2008/daiichi-sankyo-uebernimmt-aussendienst-von-merck-serono-in-frankreich/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/archiv-2008/daiichi-sankyo-erneuert-rabattvertrag-mit-aok-niedersachsen/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/archiv-2008/daiichi-sankyo-leitet-phase-iii-studie-zum-oralen-faktor-xa-inhibitor-ein/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/archiv-2008/neue-phase-ii-studienergebnisse-zum-oralen-faktor-xa-inhibitor/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/archiv-2008/daiichi-sankyo-und-inter-krankenversicherung-schliessen-rabattvertrag/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/archiv-2008/daiichi-sankyo-und-aok-saarland-schliessen-rabattvertrag/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/archiv-2008/daiichi-sankyo-gruendet-tochtergesellschaft-in-irland/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/archiv-2008/zulassung-fuer-sevikarr-in-deutschland-erhalten/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/archiv-2008/daiichi-sankyo-organisiert-europaeische-landesgesellschaften-neu/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/archiv-2008/uebernahme-des-aussendienstes-von-merck-serono-in-der-tuerkei/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/archiv-2008/daiichi-sankyo-und-huk-coburg-schliessen-rabattvertrag/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/archiv-2008/daiichi-sankyo-und-aok-schleswig-holstein-schliessen-rabattvertrag/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/archiv-2008/daiichi-sankyo-ernennt-geschaeftsfuehrer-in-der-tuerkei/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/archiv-2008/daiichi-sankyo-und-barmenia-schliessen-rabattvertrag/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/archiv-2008/daiichi-sankyo-will-aussendienst-der-merck-pharma-gmbh-uebernehmen/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/archiv-2008/daiichi-sankyo-beteiligt-sich-an-der-reduzierung-von-treibhausgasen/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/archiv-2008/daiichi-sankyo-neues-ifpma-mitglied/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/archiv-2008/daiichi-sankyo-strebt-mehrheitsanteil-bei-ranbaxy-an/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/archiv-2008/daiichi-sankyo-kauft-biotech-firma-aus-martinsried-bei-muenchen/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/archiv-2008/daiichi-sankyo-gruendet-niederlassung-in-der-tuerkei/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/archiv-2008/daiichi-sankyo-erwirbt-osteoporose-mittel-evistar-von-lilly/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/presseinformationen/ 2025-03-11T12:19:18+01:00 0.5 https://www.daiichi-sankyo.de/profil-loeschen/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/slider/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/ueber-uns/wer-wir-sind/ 2025-06-02T11:05:18+02:00 0.5 https://www.daiichi-sankyo.de/ueber-uns/wer-wir-sind/daiichi-sankyo-in-europa/ 2023-11-14T12:35:32+01:00 0.5 https://www.daiichi-sankyo.de/presse/presseinformationen/news-details/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/presse/presseinformationen/news-rss/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/pressnews-disclaimer/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/ueber-uns/daiichi-sankyo-geschichte/ 2026-02-12T08:01:14+01:00 0.5 https://www.daiichi-sankyo.de/forschung-und-entwicklung/investitionen/ 2022-12-01T14:07:24+01:00 0.5 https://www.daiichi-sankyo.de/forschung-innovation/f-und-e-netzwerk/ 2025-06-02T11:51:42+02:00 0.5 https://www.daiichi-sankyo.de/presse/pressematerial/ 2025-06-03T15:25:06+02:00 0.5 https://www.daiichi-sankyo.de/services/daiichi-sankyo-webseiten/ 2026-03-05T14:25:00+01:00 0.5 https://www.daiichi-sankyo.de/kardiovaskulaere-produkte/produktschwerpunkte/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/ueber-uns/verantwortung/transparenz/ 2026-01-19T09:12:12+01:00 0.5 https://www.daiichi-sankyo.de/datenschutz/ 2025-05-13T16:29:22+02:00 0.5 https://www.daiichi-sankyo.de/services/nebenwirkungsmeldungen/ 2025-12-10T17:28:00+01:00 0.5 https://www.daiichi-sankyo.de/karriere/ihre-karriere-bei-daiichi-sankyo-deutschland/ 2026-01-15T11:40:33+01:00 0.5 https://www.daiichi-sankyo.de/karriere/wie-es-ist-bei-uns-zu-arbeiten/ 2026-01-15T11:37:57+01:00 0.5 https://www.daiichi-sankyo.de/karriere/warum-sollten-sie-bei-uns-arbeiten/ 2026-01-15T11:39:24+01:00 0.5 https://www.daiichi-sankyo.de/karriere/ 2026-01-15T11:39:24+01:00 0.5 https://www.daiichi-sankyo.de/ueber-uns/verantwortung/nachhaltigkeit/ 2023-12-07T11:19:00+01:00 0.5 https://www.daiichi-sankyo.de/ueber-uns/verantwortung/nachhaltigkeit/umweltpolitik/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/ueber-uns/verantwortung/nachhaltigkeit/gruene-mobilitaet/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/ueber-uns/verantwortung/csr-in-europa/ein-ort-der-sich-wie-ein-zuhause-anfuehlt/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/ueber-uns/verantwortung/csr-in-europa/unterstuetzung-fuer-junge-talente/ 2022-12-01T14:07:24+01:00 0.5 https://www.daiichi-sankyo.de/ueber-uns/verantwortung/csr-in-europa/kleine-herzen/ 2023-12-07T11:21:49+01:00 0.5 https://www.daiichi-sankyo.de/forschung-und-entwicklung/tissue-and-cell-research-center/ 2022-12-01T14:07:24+01:00 0.5 https://www.daiichi-sankyo.de/kardiovaskulaere-produkte/engagement-in-der-kardiologie/ 2022-12-01T14:07:24+01:00 0.5 https://www.daiichi-sankyo.de/forschung-und-entwicklung/nicht-kommerzielle-klinische-studien/ 2024-11-20T17:26:11+01:00 0.5 https://www.daiichi-sankyo.de/ueber-uns/wer-wir-sind/unsere-werte/ 2026-02-12T08:10:38+01:00 0.5 https://www.daiichi-sankyo.de/ueber-uns/testseite-kongress-besucher/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/ueber-uns/verantwortung/unternehmensrichtlinie-zur-einhaltung-der-menschenrechte/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/kardiovaskulaere-produkte/we-care/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/kardiovaskulaere-produkte/fachinformationen/ 2026-03-18T13:56:28+01:00 0.5 https://www.daiichi-sankyo.de/onkologie/unser-engagement/ 2023-12-07T11:24:44+01:00 0.5 https://www.daiichi-sankyo.de/onkologie/unsere-geschichte/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/onkologie/brustkrebs/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/onkologie/magenkrebs/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/onkologie/lungenkrebs/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/onkologie/darmkrebs/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/onkologie/akute-myeloische-leukaemie-aml/ 2022-10-03T16:32:16+02:00 0.5 https://www.daiichi-sankyo.de/nachhaltigkeit/ 2026-02-12T08:11:53+01:00 0.5 https://www.daiichi-sankyo.de/nachhaltigkeit/berichte-leistung/ 2023-08-16T11:45:26+02:00 0.5 https://www.daiichi-sankyo.de/nachhaltigkeit/integritaetsalarm-hotline/ 2024-11-21T07:42:32+01:00 0.5 https://www.daiichi-sankyo.de/nachhaltigkeit/ethik-compliance-und-transparenz/ 2026-02-05T10:58:34+01:00 0.5 https://www.daiichi-sankyo.de/nachhaltigkeit/verantwortung-engagement/ 2026-02-05T10:58:34+01:00 0.5 https://www.daiichi-sankyo.de/nachhaltigkeit/arbeitsplatz/ 2024-11-26T15:58:15+01:00 0.5 https://www.daiichi-sankyo.de/nachhaltigkeit/umwelt-und-klimaschutz/ 2025-06-02T11:42:17+02:00 0.5 https://www.daiichi-sankyo.de/onkologie/produkte/ 2025-06-12T11:53:07+02:00 0.5 https://www.daiichi-sankyo.de/ueber-uns/dspace/ 2024-11-21T09:58:21+01:00 0.5 https://www.daiichi-sankyo.de/unsere-storys/ 2025-06-02T11:32:36+02:00 0.5 https://www.daiichi-sankyo.de/onkologie/produkte/enhertu/ 2026-02-09T14:42:47+01:00 0.5 https://www.daiichi-sankyo.de/onkologie/produkte/vanflyta/ 2026-02-09T14:55:38+01:00 0.5 https://www.daiichi-sankyo.de/unsere-storys/reiberg/ 2025-06-02T11:24:12+02:00 0.5 https://www.daiichi-sankyo.de/unsere-storys/ein-leidenschaftliches-langfristiges-bekenntnis-zu-nachhaltigkeit/ 2026-01-26T08:32:20+01:00 0.5 https://www.daiichi-sankyo.de/unsere-storys/das-bleibende-erbe-von-dr-jokichi-takamines-taka-diastase-in-medizin-und-literatur/ 2025-06-02T11:29:24+02:00 0.5 https://www.daiichi-sankyo.de/forschung-innovation/unsere-schwerpunkte/ 2024-11-28T11:00:08+01:00 0.5 https://www.daiichi-sankyo.de/onkologie/produkte/datroway/ 2025-06-26T09:21:57+02:00 0.5